AMBRoSIA: A Multicentre Biomarker Resource Strategy in ALS
Searching for unique fingerprints of MND for faster diagnosis
In order to diagnose MND faster, we need to better understand the causes of the disease. One way to do so is to identify the unique fingerprints – MND biomarkers – by obtaining biological samples from people with MND. Over the span of five years, this study will collect blood, urine and skin cells from 900 people with MND as well as from over 400 people without the disease. We are also seeking to identify biomarkers that predict how MND progresses, and why people with MND progress at different rates. This has important implications for clinical trials.
What does taking part involve?
This study recruits participants at the Barts and London MND Care Centre, Sheffield, Oxford, UCL (National Hospital) and Basildon Hospital.
Who can take part?
• People living with MND
• First-degree relatives of people with MND (e.g. parents, siblings, children)
• Healthy volunteers
How do I take part?
For further information about the study and details of how to take part, please contact:
- Sheffield - Lee Tuddenham (l.tuddenham@Sheffield.ac.uk) or Mbombe Kazoka (m.kazoka@Sheffield.ac.uk)
- Oxford - Liz Gray (email@example.com)
- London - Dr Andrea Malaspina (firstname.lastname@example.org).
This study is funded by the MND Association.
Expiry date: N/A